Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Senate Finance Committee and House Oversight Committee Take Aim at Drug Pricing

The U.S. Senate Finance Committee and the House Oversight Committee started hearings focused on high drug prices.

Read More »

EVERSANA unveils Health Strategies Insights

EVERSANA unveiled Health Strategies Insights by EVERSANA, a comprehensive market access research and insights portfolio to help life science innovators make more informed decisions.

Read More »

Walgreens settles U.S. civil fraud lawsuits

Walgreens Boots Alliance Inc. will pay $269.2 million to settle two whistleblower lawsuits accusing the pharmacy chain of civil fraud for overbilling federal healthcare programs for over a decade.

Read More »

U.S. insulin costs per patient nearly doubled from 2012 to 2016: study

The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.

Read More »

J&J raises U.S. prices on around two dozen drugs

Johnson & Johnson raised U.S. prices on around two dozen prescription drugs, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among the company’s top-selling products.

Read More »

7 Biotech Trends to Look Out for in 2019

Here are seven trends most likely to be hitting the news cycle in 2019 according to BioSpace.

Read More »

U.S. body says gene therapy may be more cost effective for spinal muscular atrophy

Biogen Inc.’s Spinraza treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG’s experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said.

Read More »

J&J unit to resolve charity kickback probe

A unit of Johnson & Johnson will pay $360 million to resolve an investigation into the company’s financial support of a charity that helped Medicare patients cover out-of-pocket drug costs.

Read More »

Merck Raised Prices Of Five Drugs In November 2018, Including Keytruda

Merck & Co. Inc. raised U.S. prices on five of the company’s drugs in November 2018 by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

Read More »

U.S. to propose TV drug ads must include list prices

The U.S. government, in an effort to increase pressure on drugmakers to lower costs for U.S. consumers, will propose requiring companies to include the price of Rx medicines in TV ads.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom